Published in PLoS One on May 01, 2014
Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis? Mult Scler Int (2015) 0.81
The MS@Work study: a 3-year prospective observational study on factors involved with work participation in patients with relapsing-remitting Multiple Sclerosis. BMC Neurol (2015) 0.81
Self-efficacy as a longitudinal predictor of perceived cognitive impairment in individuals with multiple sclerosis. Arch Phys Med Rehabil (2015) 0.78
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol (2005) 24.22
No adjustments are needed for multiple comparisons. Epidemiology (1990) 23.80
What's wrong with Bonferroni adjustments. BMJ (1998) 19.89
Financial crisis, austerity, and health in Europe. Lancet (2013) 8.34
Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis (1994) 3.59
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain (2001) 3.51
Short form of depression inventory: cross-validation. Psychol Rep (1974) 2.61
Responding to the economic crisis: a primer for public health professionals. J Public Health (Oxf) (2010) 2.25
Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry (2002) 1.64
Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol (2001) 1.64
Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler (2005) 1.38
Employment in multiple sclerosis. Exiting and re-entering the work force. J Neurol (2008) 1.37
Cognition in the early stage of multiple sclerosis. J Neurol (2006) 1.37
The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis. J Behav Med (2005) 1.34
Developing a disease-specific quality of life measure for people with multiple sclerosis. Clin Rehabil (2001) 1.31
Health status and quality of life of people with multiple sclerosis. Disabil Rehabil (2001) 1.31
The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl) (2000) 1.29
Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology (2005) 1.27
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler (2010) 1.22
The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiatry (2004) 1.17
Measuring self-efficacy in people with multiple sclerosis: a validation study. Arch Phys Med Rehabil (1996) 1.15
Measures of physical and cognitive function and work status among individuals with multiple sclerosis: a review of the literature. J Occup Rehabil (2005) 1.11
Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol (2010) 1.10
Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis. Mult Scler (2008) 1.06
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler (2008) 1.03
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study. BMC Public Health (2013) 1.00
Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice. Mult Scler Relat Disord (2013) 0.99
Cognitive impairment in multiple sclerosis. Minerva Med (2012) 0.95
Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. J Neurol Neurosurg Psychiatry (2011) 0.92
Impaired social cognition in multiple sclerosis. J Neurol Neurosurg Psychiatry (2013) 0.87
Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS One (2012) 0.86
Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler (2010) 0.85
The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Epilepsy Behav (2008) 0.85
Relevance of quality of life assessment for multiple sclerosis patients with memory impairment. PLoS One (2012) 0.85
Cognitive compensation failure in multiple sclerosis. Neurology (2010) 0.85
The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. J Neurol (2008) 0.85
Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis. Clin Neurol Neurosurg (2012) 0.83
How government spending cuts put lives at risk. Nature (2010) 0.83
EDSS variability before randomization may limit treatment discovery in primary progressive MS. Mult Scler (2012) 0.83
Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study. J Neurol Sci (2006) 0.82
Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery. BMC Neurol (2011) 0.82
[Chronically ill and unemployed? A review on vocational status in multiple sclerosis]. Fortschr Neurol Psychiatr (2013) 0.80
Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location. Mult Scler (2011) 0.80
The progress of cognitive decline in newly diagnosed MS patients. Acta Neurol Scand (2013) 0.80
Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis. J Neuropsychol (2012) 0.78